Concepedia

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

David Gancberg, Angelo Di Leo, Fátima Cardoso, Ghizlane Rouas, M. Pedrocchi, Marianne Paesmans, Alain Verhest, Chantal Bernard-Marty, Martine Piccart, Denis Larsimont

Annals of Oncology · 2002 · 309 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene

Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations

, , +14

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

, , +10

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Melody Cobleigh, Charles L. Vogel, Debu Tripathy et al. · Journal of Clinical Oncology · 1999 · 2.8K citations

, , +17

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

Michael F. Press, Giun‐Yi Hung, William Godolphin et al. · PubMed · 1994 · 483 citations

, , +17

Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

Tuula Kuukasjärvi, Ritva Karhu, Minna Tanner et al. · PubMed · 1997 · 405 citations

, , +17